Releases

21423 items in section

NeuroSense to Discuss PrimeC ALS Strategy in Upcoming Roth Webinar

As the search for effective amyotrophic lateral sclerosis treatments intensifies, NeuroSense Therapeutics is set to join a Roth Capital Partners webinar on July 8, 2026. The session will scrutinize the current clinical landscape and the strategic path forward for the company’s lead drug candidate, PrimeC.

Hawkins Way Capital Converts Chicago River North Hotel to Marriott Brand

Hawkins Way Capital has officially rebranded its River North property as the fourth location under the Series by Marriott banner, signaling a strategic shift for the Chicago hotel. Managed by FCL Management, the site now integrates into the global Marriott Bonvoy loyalty ecosystem while maintaining its original boutique character.

GELITA Targets Active Nutrition Trends at IFT FIRST 2026

As consumers shift toward proactive health and weight management, GELITA is positioning its collagen protein solutions as the key to balancing dense nutrition with sensory appeal. The company plans to showcase its latest ingredient technologies at the IFT FIRST Annual Event & Expo, running July 12–15, 2026, in Chicago.

SkyDefense Unveils CobraJet for Autonomous Counter-Drone Defense

Brighton-based SkyDefense, Inc. has introduced CobraJet, an AI-powered VTOL aircraft designed to neutralize hostile drone swarms. The modular, 3D-printed jet utilizes a hybrid propulsion system and specialized air-to-air munitions to protect critical infrastructure, military assets, and public venues from evolving aerial threats in contested environments.

Wealthfront faces securities fraud investigation following stock drop

A 16.84% single-day collapse in Wealthfront Corporation shares has triggered a formal investigation by Wolf Haldenstein Adler Freeman & Herz LLP. The law firm is probing potential securities fraud and unlawful business practices following the company's disclosure of a sharp decline in net deposits during the third quarter of fiscal year 2026.

Quantum Computing Shifts from Lab Curiosity to Strategic Asset

Government capital and looming encryption deadlines have pushed quantum technology into a volatile market inflection point. With roughly $2 billion in U.S. federal funding now committed under the CHIPS and Science Act, the industry is transitioning from speculative research toward a race for hardware scalability and post-quantum cybersecurity defense.

IceCure Expands ProSense Footprint in Brazil Following FDA Milestone

IceCure Medical is accelerating the commercial rollout of its ProSense cryoablation system across Brazil, buoyed by recent U.S. FDA clearance for early-stage breast cancer treatment. The technology, which destroys tumors through freezing, is gaining traction as a minimally invasive alternative to traditional surgery in major Brazilian medical centers.

Eliza Grayson on escaping decades of coercive control

At seventeen, Eliza Grayson was lured into an abusive relationship by a teacher who sought to evade the Vietnam War draft. Decades later, she has transformed that history of captivity into a forensic memoir, Strip Maul, detailing her escape from total control and her unlikely path to a medical degree at seventy-four.

CompTIA appoints McGraw Hill executive Sean Ryan as new CEO

Sean Ryan, a veteran education technology leader, will take the helm at CompTIA as the organization pivots to meet surging demand for artificial intelligence training. Ryan succeeds Todd Thibodeaux, who steps down after an 18-year tenure, marking a significant leadership shift for the global IT credentialing body.

Enterprises Shift Toward Federated Control to Manage AI Autonomy

Nearly 30% of organizations frequently encounter problematic AI outcomes, forcing a shift in how IT leaders manage operational authority. According to a new study by Enterprise Management Associates, firms are moving away from centralized platforms toward a federated control plane to govern increasingly autonomous workflows.

US Debt Default Clock Hits Two Minutes to Midnight

Sixty-six cents of every dollar the federal government borrows now vanishes into interest payments on past debt, a shift that has forced the Debt Default Clock to two minutes to midnight. This marks the closest the nation has stood to a fiscal crisis since the committee began tracking the gauge.

IvyBears Scales Kids Entertainment with Reversed Retail Model

With over 2.5 million YouTube subscribers and 40 million cumulative views, the IvyBears franchise is rapidly emerging as a global force in children’s media. Launched in May 2026, the animated series has turned the traditional entertainment model on its head by leveraging an existing retail presence in 60 countries.

Sunaofe Targets Remote Workers with Budget-Friendly Ergonomic Lineup

As remote work becomes a permanent fixture for the modern workforce, the makeshift home office often fails to meet long-term health needs. Los Angeles-based furniture brand Sunaofe is attempting to disrupt this market by launching a direct-to-consumer series of ergonomic chairs designed to rival premium models at significantly lower price points.

National Cold Vault Deploys Cellular Monitoring to Prevent Drug Spoilage

When facility power grids collapse during extreme weather, standard Wi-Fi-dependent refrigeration loggers go dark, leaving high-value biologics and vaccines at risk of silent destruction. Carrollton-based National Cold Vault is now countering this vulnerability by deploying an autonomous, grid-independent 4G LTE-M telemetry system designed to bypass local IT firewalls entirely.

MDJM Expands Into Supply Chain With Mirai Acquisition

By securing a controlling stake in the Japanese firm Kabushiki Kaisha Mirai on June 28, 2026, MDJM Ltd. is moving to bridge the gap between animation IP and physical retail. The deal provides the company with an established logistics network spanning more than 20 countries across Asia, Europe, and North America.

Dx&Vx Targets Global Out-Licensing After BIO USA Showcase

With over 40 meetings held at the BIO International Convention in San Diego, South Korean biotech firm Dx&Vx is accelerating its push for overseas out-licensing deals. The company leveraged the global stage to showcase its anti-cancer and obesity drug pipelines, drawing significant interest from major pharmaceutical players.

Scaling Protein Crystallography Through Laboratory Automation

As drug discovery demands higher throughput and greater reproducibility, protein crystallography laboratories are shifting toward automated workflows. A live webinar on July 24, 2026, hosted by Xtalks, will examine how researchers can integrate automated systems to refine processes from initial sample preparation to final imaging.

ePlus Expands Board with Appointment of John Lutz

John Lutz, a veteran executive with three decades of experience in global technology and institutional management, has joined the ePlus Board of Directors. Currently serving as Vice Chancellor at Vanderbilt University, Lutz will transition into a governance role, contributing to the company's audit and compensation oversight.

Capture Higher Ed Expands Enrollment Suite with Personalized Web and SMS Tools

Louisville-based Capture Higher Ed has launched two new tools for its Pathways Suite, introducing Dynamic Pages for real-time web personalization and 1:1 Texting for counselor workflows. These additions aim to move beyond generic outreach by tailoring engagement to individual student behaviors and specific funnel stages throughout the enrollment process.

CineVet Showcase Brings Veteran Filmmakers to NYC’s IFC Center

Seven short films crafted by U.S. military veterans will take center stage at the IFC Center on July 7, marking a collaborative effort between The New School, AMC Global Media, and the Future of Film initiative to highlight creative perspectives emerging from the veteran community during New York’s Fleet Week.

Leifras Partners with Ando Juku to Blend Sports and Academic Tutoring

Tokyo-based sports educator Leifras has signed a cooperation agreement with Ando Juku, a long-standing tutoring school in Mie Prefecture. The partnership aims to bridge the gap between physical activity and academic study, creating a holistic curriculum designed to foster non-cognitive traits like grit, self-esteem, and social cooperation in children.

Anixa Biosciences Advances Ovarian Cancer Therapy to Highest Dose

The first patient has been treated in the fifth cohort of an ongoing Phase 1 clinical trial for recurrent ovarian cancer, marking the highest dose level tested to date. Conducted at Moffitt Cancer Center, the study evaluates a novel CAR-T therapy targeting the follicle-stimulating hormone receptor.

Redefining Success in Obesity Clinical Trials

As competition in the weight-loss drug market reaches record intensity, clinical efficacy is no longer the sole benchmark for success. Pharmaceutical sponsors are now pivoting their trial designs to capture broader metabolic, cardiovascular, and patient-centered data to satisfy the rigorous demands of global payers and healthcare providers.

Vitalant Reports Two-Year Low in Type O Blood Reserves

With national type O blood reserves hitting their lowest point in two years, nonprofit provider Vitalant is issuing an urgent appeal for donors. The shortage, exacerbated by a decline in turnout during the recent Independence Day holiday, leaves hospitals with dwindling supplies of the most frequently transfused blood type.

Contango Silver & Gold Eliminates Hedge Book to Capture Market Upside

Contango Silver & Gold has converted its final 15,000 ounces of hedged gold into debt, effectively removing price ceilings on its future production. By restructuring its credit facility, the company aims to provide shareholders with full exposure to rising gold prices while lowering its overall interest expenses.

Nova Sets Date for Second Quarter 2026 Financial Results

Nova, the Rehovot-based semiconductor metrology firm, will report its financial results for the second quarter of 2026 on August 6. The company intends to release its performance data before the Nasdaq market opens, followed by a conference call hosted by leadership to discuss the figures with investors and analysts.

ZIM Progresses Regulatory Review for Hapag-Lloyd Merger

Regulatory hurdles remain the primary focus for ZIM Integrated Shipping Services as it moves forward with its proposed merger with Hapag-Lloyd. The Haifa-based container liner confirmed it is actively coordinating with state authorities to satisfy the necessary conditions for the transaction to proceed.

Matica Bio and VaxDome Partner on Antigen-Agnostic Vaccine Platform

College Station-based Matica Biotechnology has entered a manufacturing partnership with VaxDome to advance a novel class of antiviral-vaccine hybrids. The collaboration leverages Matica’s viral vector production capabilities to move VaxDome’s antigen-agnostic candidates—designed to counter diverse pathogens and lung cancer—from laboratory development into initial clinical trials.

Cumulus Neuroscience Integrates Muse Wearables for At-Home Sleep EEG

Clinical trials for neurodegenerative disorders are shifting from burdensome lab-based polysomnography to home-based data collection. Cumulus Neuroscience and Interaxon have integrated Muse's EEG wearable technology into the NeuLogiq platform, enabling objective, brain-based sleep measurement alongside existing assessments of cognition, mood, and speech for longitudinal research.